Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compassionate Use of Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Prospective Observational Study (Amended Protocol)

NCT04570982 is registered in ClinicalTrials.gov with Dr. Pradip Gyanwali,MD as lead sponsor.

NCT NCT04570982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04570982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compassionate Use of Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Prospective Observational Study (Amended Protocol)
Lead sponsor
Dr. Pradip Gyanwali,MD
Phase
Observational
Overall status
Unknown status
Start date
July 30, 2020
Completion date
December 30, 2020
Enrollment
200 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19